A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare®)

Infection with hepatitis B virus (HBV) continues to be a major problem in the human population. There remains a specific requirement for HBV vaccines capable of circumventing the non-responder/inadequ